Mikhail Blagoskylonny is a New York-based professor of oncology who has gained global recognition due to his outstanding research in cancer and aging. The scientist has made significant discoveries that have greatly helped in improving the oncology sector. He currently does his research work at the Rosewell Park Cancer Institute and has been serving it as a professor since 2009. The scientist has also been involved in writing and publishing a couple of valuable material that focuses on aging and cancer. He is recognized for encouraging medical professionals across the globe to use Rapamycin in prolonging the lives of their patients. Blagoskylonny has gained respect in the medical research field due to his excellent knowledge of oncology.According to the scientist’s research work, Rapamycin has outstanding properties that can make it the best drug for treating cancer. The medicine is currently used for curing other life-threatening conditions that include lymphangioleiomyomatosis (LAM), hemolytic-uremic syndrome, tuberous sclerosis complex (TSC), and facial angiofibromas.
It can be accessed in pharmacies across the globe, and its local name is Rapamune. Rapamycin has been used since 1972 when it was discovered from a strain of bacteria that was on Eastern Island. It was initially used as an anti-fungal agent before professionals learned about its properties as an immunosuppressive and antiproliferative.The scientist has been acknowledged for making significant discoveries towards the development targeted cancer therapies. He has also conducted unparalleled researched on ideal cancer and anti-aging cures. Blagosklonny’ believes that cancer is related to aging since it mostly affects individuals who have passed a specific age. He is a role model to his workmates and students due to his accomplishments in the oncology sector.Blagosklonny’s career has blossomed because of his remarkable academic qualification. The professor got his Ph.D. from the First Pavlov State Medical University of St. Peterburg. He was also awarded a masters’ degree in internal medicine from the institution. The scientist’s career began in 2002 when he joined the New York Medical College to work as a researcher.
After gaining some experience, he was hired by the Ordway Research Institute to act as a senior researcher before moving to Roswell Park Cancer Institute in 2009. His role as a professor at the institute has been acknowledged since he has assisted in the invention of various targeted cancer treatments. Mikhail has also studied a lot about the aging mechanism and anti-aging drugs development. The latest research project that he is conducting is focused on discovering how aging and cancer are affected by the TOR signal.Mikhail Blagoskylonny has also established a successful career as an editor in different fields in the medical research industry. The professor has excellent knowledge of the cell cycle, aging, and oncotaget and is currently an editor-in-chief in all the areas. He has also been chosen to serve as an editor in research fields such as cancer biology and therapy. The publications that he has written are currently used by researchers and professionals who are interested in acquiring knowledge about oncology.